| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |